The pharma company’s net profit soared 77.1% year-on-year (YoY) in Q3FY25 to ₹82.9 crore from ₹46.8 crore in the same period last year. Revenue from operations surged 39.8% to ₹307.2 crore, up from ₹219.8 crore in Q3FY24.
The pharma company’s net profit soared 77.1% year-on-year (YoY) in Q3FY25 to ₹82.9 crore from ₹46.8 crore in the same period last year. Revenue from operations surged 39.8% to ₹307.2 crore, up from ₹219.8 crore in Q3FY24.